Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Departments, Divisions and Centers
Search by expertise, name or affiliation
Natalizumab and PML: A risky business?
David B. Clifford
Department of Neurology
Institute of Clinical and Translational Sciences
Division of AIDS and Infectious Disease
Institute for Public Health
Contribution to journal
Dive into the research topics of 'Natalizumab and PML: A risky business?'. Together they form a unique fingerprint.